Literature DB >> 20384605

Individualized optimization of the screening interval for diabetic retinopathy: a new model.

Jesper Mehlsen1, Mogens Erlandsen, Per Løgstrup Poulsen, Toke Bek.   

Abstract

INTRODUCTION: Screening programmes for diabetic retinopathy follow guidelines that ensure that vision-threatening complications are detected even when the disease progression is fast. This implies that patients with slow disease progression will be recommended examinations more often than needed.
METHOD: On the basis of previously defined individual risk factors, multiple logistic regression was used to develop a model for individualized determination of the screening interval in diabetic retinopathy, while adjusting for the fact that in the data set used to construct the model, the screening interval acted as a time-dependent confounder. The model was tested on 1372 patients screened during year 2000.
RESULTS: It was possible to construct a model for calculating the optimal screening interval in low-risk patients in whom the recommended screening interval was longer than 12 months. When the probability of reaching a treatment requiring event was set to 0.5%, none of the patients reached a treatment end-point in a validation of the model, and the screening interval was prolonged on average 2.9 times in patients with type 1 diabetes and 1.2 times in those with type 2 diabetes. The predictive strength of the model depended on the number of variables included.
CONCLUSIONS: It is possible to construct a model for optimizing the examination interval during screening for diabetic retinopathy in low-risk patients. The model can potentially be improved by identifying unknown or unmeasured confounders and by including knowledge of risk factors before and after the examination on the basis of which the prediction is made.
© 2010 The Authors. Acta Ophthalmologica © 2010 Acta Ophthalmologica Scandinavica Foundation.

Entities:  

Mesh:

Year:  2010        PMID: 20384605     DOI: 10.1111/j.1755-3768.2010.01882.x

Source DB:  PubMed          Journal:  Acta Ophthalmol        ISSN: 1755-375X            Impact factor:   3.761


  16 in total

Review 1.  Toward Big Data Analytics: Review of Predictive Models in Management of Diabetes and Its Complications.

Authors:  Simon Lebech Cichosz; Mette Dencker Johansen; Ole Hejlesen
Journal:  J Diabetes Sci Technol       Date:  2015-10-14

2.  Prognostic prediction models for diabetic retinopathy progression: a systematic review.

Authors:  Sajjad Haider; Salman Naveed Sadiq; David Moore; Malcolm James Price; Krishnarajah Nirantharakumar
Journal:  Eye (Lond)       Date:  2019-01-16       Impact factor: 3.775

3.  Individual risk assessment and information technology to optimise screening frequency for diabetic retinopathy.

Authors:  T Aspelund; O Thornórisdóttir; E Olafsdottir; A Gudmundsdottir; A B Einarsdóttir; J Mehlsen; S Einarsson; O Pálsson; G Einarsson; T Bek; E Stefánsson
Journal:  Diabetologia       Date:  2011-07-27       Impact factor: 10.122

4.  Reduced baseline diameter and contraction of peripheral retinal arterioles immediately after remote ischemia in diabetic patients.

Authors:  Yasmin El Dabagh; Line Petersen; Michael Pedersen; Toke Bek
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2019-07-04       Impact factor: 3.117

Review 5.  Diabetic retinopathy screening in the emerging era of artificial intelligence.

Authors:  Jakob Grauslund
Journal:  Diabetologia       Date:  2022-05-31       Impact factor: 10.460

6.  Retinal oxygen saturation changes progressively over time in diabetic retinopathy.

Authors:  Sveinn Hakon Hardarson; Einar Stefánsson; Toke Bek
Journal:  PLoS One       Date:  2021-05-12       Impact factor: 3.240

Review 7.  The Role of Telemedicine, In-Home Testing and Artificial Intelligence to Alleviate an Increasingly Burdened Healthcare System: Diabetic Retinopathy.

Authors:  Janusz Pieczynski; Patrycja Kuklo; Andrzej Grzybowski
Journal:  Ophthalmol Ther       Date:  2021-06-22

8.  Predicted impact of extending the screening interval for diabetic retinopathy: the Scottish Diabetic Retinopathy Screening programme.

Authors:  H C Looker; S O Nyangoma; D T Cromie; J A Olson; G P Leese; S Philip; M W Black; J Doig; N Lee; A Briggs; E J Hothersall; A D Morris; R S Lindsay; J A McKnight; D W M Pearson; N A Sattar; S H Wild; P McKeigue; H M Colhoun
Journal:  Diabetologia       Date:  2013-05-21       Impact factor: 10.122

9.  A simple risk stratification for time to development of sight-threatening diabetic retinopathy.

Authors:  Irene M Stratton; Stephen J Aldington; David J Taylor; Amanda I Adler; Peter H Scanlon
Journal:  Diabetes Care       Date:  2012-11-12       Impact factor: 19.112

10.  The influence of background diabetic retinopathy in the second eye on rates of progression of diabetic retinopathy between 2005 and 2010.

Authors:  Peter H Scanlon; Irene M Stratton; Mark Histed; Steve J Chave; Stephen J Aldington
Journal:  Acta Ophthalmol       Date:  2013-04-01       Impact factor: 3.761

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.